ADVFN Logo ADVFN
Donnée du Marché
Actualité
Outils
Donnée du Marché
Discover

Hot Features

Follow Feed

Rester connecter avec les traders et investisseurs dans notre communauté Follow Feed.

Flux des Options

Explorez des données complètes sur les options et utilisez les filtres avancés avec Options Flow.

Moniteur

Organisez et surveillez vos d'actions et actifs avec le Moniteur.
Se connecter Premium IconPremium Help Menu
CAC 40
8 111,63
0,11%
Dow Jones
43 840,91
1,39%
DAX
22 551,43
0,12%
Brent Oil
73,045
0,00%
Bitcoin
85 357,72
1,17%
Registration Strip Icon for monitor Surveillez plusieurs cotations en temps réel des principales bourses, telles que Euronext Paris, NASDAQ, NYSE, AMEX, Bovespa et plus encore.
S'inscrire
  1. Accueil
  2. Investir
  3. Actions
  4. Etats-Unis
  5. NASDAQ
  6. Lisata Therapeutics Inc (LSTA)

  7. Lisata Therapeutics Inc (LSTA) Actualités

LSTA

Lisata Therapeutics (LSTA)

Lisata Therapeutics Inc
De:
Trier par:
 Showing the most relevant articles for your search:NASDAQ:LSTA
DateHeureSourceTitreSymboleSociété
27/02/202522h05GlobeNewswire Inc.Lisata Therapeutics Reports Full Year 2024 Financial Results and Provides Business UpdateNASDAQ:LSTALisata Therapeutics Inc
20/02/202514h00GlobeNewswire Inc.Lisata Therapeutics to Report Full Year 2024 Financial Results and Provide a Business Update on Thursday, February 27, 2025NASDAQ:LSTALisata Therapeutics Inc
05/02/202514h30GlobeNewswire Inc.Lisata Therapeutics to Present at the 2025 BIO CEO & Investor ConferenceNASDAQ:LSTALisata Therapeutics Inc
23/01/202514h00GlobeNewswire Inc.Lisata Therapeutics and WARPNINE Announce Encouraging Preliminary Results from the Phase 1b/2a iLSTA Trial Evaluating Certepetide in Locally Advanced Non-Resectable Pancreatic Ductal AdenocarcinomaNASDAQ:LSTALisata Therapeutics Inc
22/01/202514h00GlobeNewswire Inc.Lisata Therapeutics Reports Encouraging Preliminary Cohort A Data from the AGITG-led Phase 2 ASCEND Trial Evaluating Certepetide with Standard-of-Care Chemotherapy in Metastatic Pancreatic Ductal AdenocarcinomaNASDAQ:LSTALisata Therapeutics Inc
15/01/202514h30GlobeNewswire Inc.Lisata Therapeutics to Present at the 2025 Sequire Investor SummitNASDAQ:LSTALisata Therapeutics Inc
10/12/202414h30GlobeNewswire Inc.Lisata Therapeutics Announces Completion of Enrollment in the CENDIFOX TrialNASDAQ:LSTALisata Therapeutics Inc
03/12/202414h30GlobeNewswire Inc.Lisata Therapeutics and Kuva Labs Announce Global License Agreement for Solid Tumor ImagingNASDAQ:LSTALisata Therapeutics Inc
19/11/202414h30GlobeNewswire Inc.Lisata Therapeutics Wins 2024 BioTech Breakthrough Award for ‘Specialized BioTherapeutics Company of the Year’NASDAQ:LSTALisata Therapeutics Inc
12/11/202422h05GlobeNewswire Inc.Lisata Therapeutics Reports Third Quarter 2024 Financial Results and Provides Business UpdateNASDAQ:LSTALisata Therapeutics Inc
06/11/202415h23GlobeNewswire Inc.Lisata Therapeutics and Valo Therapeutics Announce Preclinical Research CollaborationNASDAQ:LSTALisata Therapeutics Inc
06/11/202414h30GlobeNewswire Inc.Lisata Therapeutics to Report Third Quarter 2024 Financial Results and Provide a Business Update on Tuesday, November 12, 2024NASDAQ:LSTALisata Therapeutics Inc
31/10/202413h30GlobeNewswire Inc.Lisata Therapeutics to Participate in Upcoming November 2024 Industry and Investor EventsNASDAQ:LSTALisata Therapeutics Inc
28/10/202413h30GlobeNewswire Inc.Lisata Therapeutics Announces Sponsored Preclinical Research Agreement with the University of Cincinnati to Study Certepetide for the Treatment of EndometriosisNASDAQ:LSTALisata Therapeutics Inc
03/10/202414h00GlobeNewswire Inc.Lisata Therapeutics to Participate in Upcoming October 2024 Industry and Investor EventsNASDAQ:LSTALisata Therapeutics Inc
17/09/202414h00GlobeNewswire Inc.Lisata Therapeutics Announces First Patient Treated in the Second-line Cholangiocarcinoma Cohort of the BOLSTER TrialNASDAQ:LSTALisata Therapeutics Inc
09/09/202414h00GlobeNewswire Inc.Lisata Therapeutics to Participate in Upcoming September 2024 Industry and Investor EventsNASDAQ:LSTALisata Therapeutics Inc
05/09/202414h00GlobeNewswire Inc.Lisata Therapeutics’ Certepetide Granted FDA Orphan Drug Designation for the Treatment of CholangiocarcinomaNASDAQ:LSTALisata Therapeutics Inc
12/08/202422h05GlobeNewswire Inc.Lisata Therapeutics Reports Second Quarter 2024 Financial Results and Provides Business UpdateNASDAQ:LSTALisata Therapeutics Inc
05/08/202414h00GlobeNewswire Inc.Lisata Therapeutics to Report Second Quarter 2024 Financial Results and Provide a Business Update on Monday, August 12, 2024NASDAQ:LSTALisata Therapeutics Inc
18/07/202414h00GlobeNewswire Inc.Haystack Oncology and Lisata Therapeutics Initiate Research Collaboration to Use the Haystack MRD™ Technology to Evaluate Efficacy of Pancreatic Cancer TherapyNASDAQ:LSTALisata Therapeutics Inc
16/07/202414h00GlobeNewswire Inc.Lisata Therapeutics Announces Completion of Enrollment in its Phase 2a BOLSTER Trial of Certepetide in First-Line CholangiocarcinomaNASDAQ:LSTALisata Therapeutics Inc
10/07/202414h00GlobeNewswire Inc.Lisata Therapeutics’ Certepetide Shows Promise in Improving Standard Treatment for Intrahepatic Cholangiocarcinoma in a Preclinical ModelNASDAQ:LSTALisata Therapeutics Inc
13/06/202414h30GlobeNewswire Inc.Lisata Therapeutics Announces Full Enrollment of Pancreatic Cancer Cohort of CENDIFOX TrialNASDAQ:LSTALisata Therapeutics Inc
28/05/202414h30GlobeNewswire Inc.Lisata Therapeutics to Participate in Upcoming June 2024 Industry and Investor EventsNASDAQ:LSTALisata Therapeutics Inc
20/05/202414h30GlobeNewswire Inc.Lisata Therapeutics Receives Paediatric Investigation Plan Waiver from the European Medicines Agency for Certepetide in Pancreatic CancerNASDAQ:LSTALisata Therapeutics Inc
10/05/202406h15Edgar (US Regulatory)Form EFFECT - Notice of EffectivenessNASDAQ:LSTALisata Therapeutics Inc
09/05/202422h13Edgar (US Regulatory)Form 10-Q - Quarterly report [Sections 13 or 15(d)]NASDAQ:LSTALisata Therapeutics Inc
09/05/202422h05GlobeNewswire Inc.Lisata Therapeutics Reports First Quarter 2024 Financial Results and Provides Business UpdateNASDAQ:LSTALisata Therapeutics Inc
08/05/202414h00GlobeNewswire Inc.Lisata Therapeutics to Participate in Upcoming May 2024 Industry and Investor EventsNASDAQ:LSTALisata Therapeutics Inc
 Showing the most relevant articles for your search:NASDAQ:LSTA

Dernières Valeurs Consultées

USOTC
ZOONF
Zoono (PK)
TG
ZA4
Lithium ION Energy
AMEX
GMF
SPDR S&P Emerging Asia P...
Delayed Upgrade Clock
ADVFN Logo
InvestorsHub

France
Société
Entreprise
Popular
Obtenir l'application
App Store
Google Play

Assistance: support@advfn.fr

En accédant aux services disponibles de ADVFN, vous acceptez les Conditions Générales de ADVFN Conditions Générales

© 2025 ADVFN PLC - Tous droits réservés

Supprimer les publicités

Inscrivez-vous pour une expérience sans publicité

Aucune publicité

Essayez maintenant

Conserver les annonces